• 제목/요약/키워드: oral delivery

검색결과 325건 처리시간 0.031초

Magnetofection is an efficient tool for ectopic gene expression into oral cells

  • Ji, Jae-Hoon;Ko, Seon-Yle;Jang, Young-Joo
    • International Journal of Oral Biology
    • /
    • 제32권1호
    • /
    • pp.7-11
    • /
    • 2007
  • It is difficult to introduce DNA in non-invasive manner into oral cancer cells as well as primary cells for gene manipulation and expression in vivo. So far, several methods for a gene delivery have been performed to solve this problem. Magnetofection is one of the recent methods for gene transfer, and nanoparticles are applied under a magnetic field for DNA delivery. We investigated whether the magnetofection increases the efficiency of a gene delivery into several oral cell lines. By using a plasmid coding the green fluorescent protein (GFP), the efficiency of gene transfer by magnetofection was compared with those by using the calcium phosphate and the commercial transfection agent. Indeed, the magnetofection increased the green fluorescent signal in cells, suggested that this method apparently enhance the efficiency of gene delivery without any defects in various oral cancer cell lines. Finally, we have shown that magnetofection can be a useful technique for gene delivery to difficult-to-transfect cells to perform a functional study of genes in vivo.

Protein Drug Oral Delivery: The Recent Progress

  • Lee, Hye-J.
    • Archives of Pharmacal Research
    • /
    • 제25권5호
    • /
    • pp.572-584
    • /
    • 2002
  • Rapid development in molecular biology and recent advancement in recombinant technology increase identification and commercialization of potential protein drugs. Traditional forms of administrations for the peptide and protein drugs often rely on their parenteral injection, since the bioavailability of these therapeutic agents is poor when administered nonparenterally. Tremendous efforts by numerous investigators in the world have been put to improve protein formulations and as a result, a few successful formulations have been developed including sustained-release human growth hormone. For a promising protein delivery technology, efficacy and safety are the first requirement to meet. However, these systems still require periodic injection and increase the incidence of patient compliance. The development of an oral dosage form that improves the absorption of peptide and especially protein drugs is the most desirable formulation but one of the greatest challenges in the pharmaceutical field. The major barriers to developing oral formulations for peptides and proteins are metabolic enzymes and impermeable mucosal tissues in the intestine. Furthermore, chemical and conformational instability of protein drugs is not a small issue in protein pharmaceuticals. Conventional pharmaceutical approaches to address these barriers, which have been successful with traditional organic drug molecules, have not been effective for peptide and protein formulations. It is likely that effective oral formulations for peptides and proteins will remain highly compound specific. A number of innovative oral drug delivery approaches have been recently developed, including the drug entrapment within small vesicles or their passage through the intestinal paracellular pathway. This review provides a summary of the novel approaches currently in progress in the protein oral delivery followed by factors affecting protein oral absorption.

Pharmaceutical Devices for Oral Cavity-based Local and Systemic Drug Delivery

  • Yun, Gyi-Ae;Choi, Sung-Up;Park, Ki-Hwan;Rhee, Yun-Seok;Lee, Beom-Jin;Lee, Jae-Hwi
    • Journal of Pharmaceutical Investigation
    • /
    • 제40권spc호
    • /
    • pp.113-118
    • /
    • 2010
  • Pharmaceutical technology has primarily focused on the development of the best dosage forms depending on the route of administration. The design of dosage forms is greatly influenced by the route of administration. Due to a variety of advantages such as avoidance of first-pass effect, abundant blood supply and easy access to the absorption site, the oral cavity has frequently been selected as a site for drug delivery. Since the oral cavity is relatively unique from the anatomical and physiological viewpoint, one should always consider these conditions when designing the drug delivery systems for the oral cavity. In this regard, the current review paper was prepared to summarize the essential features of the drug delivery systems utilized in the oral cavity, along with the introduction of various dosage forms developed to date.

장애인의 구강건강권 확립을 위한 구강의료 서비스 전달 시스템 개발 (DEVELOPING ORAL HEALTH SERVICE DELIVERY SYSTEM FOR THE DISABLED)

  • 백혜란;김소연;진보형;이재영;임영우;김영재
    • 대한장애인치과학회지
    • /
    • 제14권2호
    • /
    • pp.111-120
    • /
    • 2018
  • The need for oral health rights for people with disabilities is very high, and current oral health care system does not fully reflect these demands. Efforts to promote oral health of people with disabilities are urgently needed. In order for the disabled to have oral health rights, access to oral health services for people with disabilities should be improved and barriers to access should be resolved. In this study, we propose oral health service delivery system to guarantee oral health rights for the disabled. In addition, before applying the proposed oral medical delivery system, the external effects of the system application were predicted and the expert verification was conducted to find out the solution. There are some controversies about the development of the service delivery system proposed in this study. As a result of the expert verification, there were disagreements about the suitability of the service provider, the suitability of the service recipient, the appropriateness of the service content and scope, and the appropriateness of the cost and the revenue source. Subsequent Delphi surveys require the development of structured questionnaires for discussions that require consensus. It is expected that a reasonable consensus of expert opinions will be derived.

구강건강 관련 스마트폰 애플리케이션 분석 (Analysis of oral health-related smartphone applications)

  • 정재연;김수화
    • 한국치위생학회지
    • /
    • 제19권4호
    • /
    • pp.493-502
    • /
    • 2019
  • Objectives: This study aimed to investigate the current status of oral health applications developed for smartphones because they can be used as a new educational medium to manage and improve oral health. Methods: This study examined 60 basic oral health applications provided by Google Play Store and Apple App Store as of May 2019 and examined delivery contents, delivery methods, application types, and other information. Results: Apple included 65.4% of oral apps in the game category whereas Android included 64.3% in the education category (p>0.05). All Apple's apps and 71.4% of Android apps were developed overseas (p<0.01). The delivery contents were 61.5% for Brushing + tooth decay in Apple, and 78.6% for others (oral care products and gum diseases) in Android (p>0.05). For the delivery method, game + video was 65.4% in Apple, and game and other methods (text, image, augmented reality) was 42.9% in Android (p>0.05). In the case of application type, play type was the most common with 88.5% in Apple, and 46.4% play type and 39.3% other type (text, appreciation, problem-solving types) in Android (p<0.01). In addition, play type was high in both education (53.8%) and game (90.0%) categories (p>0.05). The average review score was 4.30 in the education category, 4.34 in the case of brushing and care (delivery contents), 4.37 in the case of using game + video (delivery methods), and 4.57 in the case of Play + other types (application type) (p>0.05). Conclusions: The use of healthcare apps is expected to increase owing to improved lifestyles, an increase in the elderly population, cost-effectiveness, and convenience that is not affected by time and place. Effective use of oral health apps will require the participation of dental professionals in the development process to identify the exact status, expand subjects, and provide appropriate information.

임부의 영유아 구강보건지식에 미치는 영향 (Effect on Infantile Oral Health Knowledge in Pregnant Women)

  • 강현경;이선옥
    • 보건의료산업학회지
    • /
    • 제8권1호
    • /
    • pp.125-134
    • /
    • 2014
  • The purpose of this study was to identify influencing factors associated with infantile oral health knowledge among pregnant women. The participants were 300 pregnant women who agreed to participate in this study. The data were analyzed with descriptive statistics, t-test, ANOVA, Pearson correlation, and simultaneous multiple regression using the SPSS 21.0 ver program. Findings of the study can be summarized as follows. First, the infantile oral health knowledge of primigravida total score was $28.80{\pm}3.02$, and multigravida total score was $30.23{\pm}2.94$. Second, infantile oral health knowledge different according to education, experience of delivery, experience of oral health education and need of oral health education, Third, a positive correlation existed between need of oral health education, experience of delivery, education, and experience of oral health education. Forth, the predictors that affect the infantile oral health knowledge were experience of delivery, need of oral health education, experience of oral health education, education,. Consequently, it was necessary to encourage primigravida to take part in infantile oral health education program and oral health projects.

측두하악관절의 골관절염에 대한 교합안정장치의 치료효과 (Effect of Occlusal Stabilizing Splint for Osteoarthritis of Temporomandibular Joint)

  • 김지현;전혜미;옥수민;허준영;정성희;안용우;고명연
    • Journal of Oral Medicine and Pain
    • /
    • 제37권2호
    • /
    • pp.113-123
    • /
    • 2012
  • 2009년부터 2011년까지 부산대학교병원 구강내과에 측두하악관절장애를 주소로 내원한 환자 중 임상검사와 방사선 검사 및 전산화 단층(Cone beam Computed tomographic view)촬영으로 측두하악관절의 골관절염으로 진단된 76명의 환자를 대상으로 초진 시와 교합안정장치 장착 전까지 물리치료 및 약물치료를 시행하고 교합안정장치 장착 시부터 최종 내원 시까지 월 1회 장치조정을 시행하여 시기별 치료결과를 비교하여 다음과 같은 결과를 얻었다. 1. 초진 시와 교합안정장치 장착 시와 최종 내원 사이에 모든 증상의 변화가 유의한 차이가 있게 개선되었다. 2. 교합안정장치 치료 전까지 치료에서는 급성군에서 통증과 관절잡음이 유의하게 개선되었고, 만성군에서 통증, 관절잡음, 개구제한 및 최대편이개구량이 모두 개선되었다. 3. 교합안정장치 장착 후에는 급성군에서 통증, 개구제한과 최대편이개구량이 유의하게 개선되었고, 만성군에서 통증, 관절잡음과 개구제한이 유의하게 개선되었다.

Cholesterol conjugated spermine as a delivery modality of antisense oligonucleotide

  • Im, Yoon Kyung;Kim, Myung Su;Yoo, Hoon
    • International Journal of Oral Biology
    • /
    • 제38권4호
    • /
    • pp.155-160
    • /
    • 2013
  • The major issue in the development of nucleic acid based therapeutics is the inefficient delivery of these agents into cells. We prepared cholesterol conjugated spermine and evaluated its usefulness as a delivery modality for antisense oligonucleotides in HeLa-Luc cells. A 2'-O-methyl antisense oligonucleotide sequence, designed to correct splicing at an aberrant intron inserted into a normal luciferase reporter gene, was used for complex formation with cholesterol conjugated spermine. Effective delivery of this antisense agent into nucleus would results in the expression of a luciferasereporter gene product. The cholesterol-spermine formed stable complexes with the antisense oligonucleotide and showed modest delivery activity. Furthermore, this delivery activity was maintained even in the presence of serum proteins, mimicking in vivo conditions. Cholesterol-spermine thus has potential as a delivery system for antisense oligonucleotides into cells.

고분자 코팅을 이용한 경구용 리포좀의 개발(I): 다당체로 코팅된 리포좀의 담즙산염에 대한 안정성 (Polymer-Coated Liposomes for Oral Drug Delivery (I): Stability of Polysaccharide-Coated Liposomes Against Bile Salts)

  • 최영욱;한양희
    • Journal of Pharmaceutical Investigation
    • /
    • 제22권3호
    • /
    • pp.211-217
    • /
    • 1992
  • Stabilization of liposomes against degradation by bile salts has been investigated in order to develop a liposomal model system for oral drug delivery. Two polysaccharides, amylopectin (AP) and chitin (CT), were employed to coat both empty liposomes and bromthymol blue (BTB)-encapsulated liposomes by adsorption-coating techniques. Turbidity changes and BTB-release characteristics in pH 5.6 buffer solutions with or without bile salts, sodium cholate and sodium glycocholate, were observed to compare the differences between uncoated liposomes and polysaccharide-coated liposomes. Initial turbidities of both uncoated and polysaccharide-coated liposomes in buffer solution were kept constant within 3% range during 4 hours of experiments. But they were decreased in a different manner in bile salts-containing buffer solutions, showing 10% or less decrease for polysaccharide-coated liposomes and 25% or more decrease for uncoated liposomes. BTB release from uncoated liposomes has been greatly increased upto 90% after 4 hours in bile salts-containing buffer solution, which is a clue for breakdown of liposomal vesicles. However, polysaccharide-coated liposomes showed the controlled-release pattern which is proportional to square-root of time, followed by around 50% release for the same time period. Consequently, it is possible to conclude that these polysaccharide-coated liposomes might be an available system for oral delivery of a drug which is unstable in gut environment.

  • PDF

Multivesicular Liposomes for Oral Delivery of Recombinant Human Epidermal Growth Factor

  • Li Hong;An Jun Hee;Park Jeong-Sook;Han Kun
    • Archives of Pharmacal Research
    • /
    • 제28권8호
    • /
    • pp.988-994
    • /
    • 2005
  • The purpose of the present study was to prepare multivesicular liposomes with a high drug loading capacity and to investigate its potential applicability in the oral delivery of a peptide, human epidermal growth factor (rhEGF). The multivesicular liposomes containing rhEGF was prepared by a two-step water-in-oil-in-water double emulsification process. The loading efficiency was increased as rhEGF concentration increased from 1 to 5mg/mL, reaching approximately $60\%$ at 5 mg/mL. Approximately $47\%$ and $35\%$ of rhEGF was released from the multivesicular liposomes within 6 h in simulated intra-gastric fluid (pH 1.2) and intra-intestinal fluid (pH 7.4), respectively. rhEGF-loaded multivesicular liposomes markedly suppressed the enzymatic degradation of the peptide in an incubation with the Caco-2 cell homogenate. However, the transport of rhEGF from the multivesicular liposomes to the basolateral side of Caco­2 cells was two times lower than that of the rhEGF in aqueous solution. The gastric ulcer healing effect of rhEGF-loaded multivesicular liposomes was significantly enhanced compared with that of rhEGF in aqueous solution; the healing effect of the liposomes was comparable to that of the cimetidine in rats. Collectively, these results indicate that rhEGF-loaded multivesicular liposomes may be used as a new strategy for the development of an oral delivery system in the treatment of peptic ulcer diseases.